Spring Mountain Capital

Spring Mountain Capital, established in 2001 and based in New York, is a growth equity investment firm. It focuses on providing expansion capital to companies in the U.S. that operate in sectors experiencing significant change and high growth potential, such as enterprise software, technology-enabled services, digital health, and healthcare services. The firm invests principally in the lower middle market, seeking to back companies that are capitalizing on breakthrough innovations, paradigm shifts, or fundamental market or behavioral changes.

Jason Orchard

Managing Director and Head of Total Return

Kenneth Soll

Principal

52 past transactions

Yunu

Seed Round in 2025
Yunu is a med-tech company focused on enhancing medical research through its innovative platform. This platform facilitates access to clinical trial and experimental data, fostering collaboration among researchers and healthcare professionals globally. By integrating medical imaging insights, Yunu streamlines communication between radiologists and oncologists, while also connecting various stakeholders such as study teams, sponsors, core labs, and clinical research organizations. This approach aims to accelerate the development of therapies and improve the overall efficiency of healthcare operations, ultimately enhancing data integrity and accessibility for all.

Hiveclass

Seed Round in 2025
Hiveclass is a developer of a digital content mobile platform focused on youth sports training and physical education. The company creates original athlete-led training videos covering a variety of popular sports and fitness activities, including basketball, soccer, volleyball, tennis, dance, and self-defense. By providing engaging content, Hiveclass encourages children to participate in physical activities, fostering connections with other athletes while learning new techniques and mastering skills in a fun environment.

Wingtra

Series B in 2024
Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.

Thentia Cloud

Series B in 2024
Thentia Cloud is a leading company that specializes in providing regulatory, compliance, and governance database services. The company leverages proprietary technology to assist regulatory bodies in efficiently meeting their obligations. Thentia serves a diverse range of clients across Canada and the United States, offering cutting-edge software solutions and industry-leading expertise in regulatory standards. Their product suite includes a secure, user-friendly platform for regulators and a cloud-based compliance solution designed for private businesses, boards of directors, committees, executive teams, and stakeholders. This enables both public and private entities to maintain high standards of regulatory excellence in a timely and professional manner.

showd.me

Series A in 2023
Showd.me is an enterprise peer-to-peer learning platform designed to facilitate employee training and development within organizations. The platform enables employees to share knowledge and skills through various cross-platform tools, including keyword skill search, chat, video, file sharing, and email integration. This approach allows for efficient onboarding of new hires, development of employee expertise, and the identification of potential career paths. Additionally, Showd.me offers online compliance training, particularly in healthcare, which supports remote and on-demand learning. By providing a comprehensive suite of training and professional development services, Showd.me helps organizations reduce in-service costs while enhancing employee capabilities.

ProSomnus Sleep Technologies

Post in 2023
ProSomnus Sleep Technologies is a medical device manufacturer based in Pleasanton, California, specializing in precision, mass-customized oral appliance therapy devices for the treatment of obstructive sleep apnea. Founded in 2016, the company focuses on enhancing patient comfort and treatment efficacy through its flagship products, the ProSomnus [IA] and MicrO2 Sleep and Snore Devices. These innovative oral appliances are designed to help dentists facilitate faster patient therapy initiation while improving compliance and minimizing side effects. ProSomnus's devices represent a less invasive alternative to traditional continuous positive airway pressure therapy, addressing the needs of the over 74 million Americans affected by sleep apnea and associated health conditions such as heart failure and diabetes.

Rayleigh Acoustics

Series A in 2023
Rayleigh Acoustics is an audio product design company that offers design solutions including ID, acoustics, structure, hardware, and software.

Recess

Series A in 2022
Recess is an experiential partnership marketing platform that facilitates brand engagement through event and venue collaborations across the United States. Founded in 2013 and headquartered in Marina del Rey, California, the company provides a comprehensive online solution that allows brands and agencies to discover, execute, and measure marketing activations at large-scale events. Recess partners with universities to connect brands with college students and organizes various initiatives, including music festivals and interactive networking events, aimed at inspiring entrepreneurs and startups. Its services include turnkey item distribution and on-site activation, enabling brands to engage directly with a vast consumer base. By offering centralized contracting, payment, and logistics, Recess streamlines the partnership process, helping clients save time and achieve measurable return on investment.

Vergent Bioscience

Series B in 2022
Vergent Bioscience, Inc. is a company focused on improving cancer surgery outcomes through the development of molecularly-targeted imaging probes. Founded in 2013 and based in Minneapolis, Minnesota, Vergent manufactures a tumor-targeted fluorescent probe, known as VGT-309, which binds to enzymes overexpressed in various cancerous tissues. Upon injection prior to surgery, this probe activates a bright fluorescing dye that illuminates cancerous cells, allowing surgeons to differentiate between malignant and normal tissue with enhanced clarity. By providing a clear visual guide during surgical procedures, Vergent's technology aims to facilitate the complete removal of tumors and reduce the likelihood of residual cancer, thereby addressing a critical need in the surgical oncology field. The company's innovative approach is applicable to multiple cancer types, including lung, breast, ovarian, colorectal, and brain cancers, and is designed to support advanced visualization in various surgical techniques, including open, laparoscopic, and robotic surgeries.

Thentia Cloud

Series B in 2022
Thentia Cloud is a leading company that specializes in providing regulatory, compliance, and governance database services. The company leverages proprietary technology to assist regulatory bodies in efficiently meeting their obligations. Thentia serves a diverse range of clients across Canada and the United States, offering cutting-edge software solutions and industry-leading expertise in regulatory standards. Their product suite includes a secure, user-friendly platform for regulators and a cloud-based compliance solution designed for private businesses, boards of directors, committees, executive teams, and stakeholders. This enables both public and private entities to maintain high standards of regulatory excellence in a timely and professional manner.

Genomenon

Series B in 2022
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and discovery. Founded in 2014, it provides a suite of diagnostic and discovery solutions that enable physicians, researchers, and pharmaceutical companies to rapidly and accurately identify disease-causing variants from genomic sequencing data. The company’s flagship product, GENOMENON, automates the analysis of next-generation sequencing data, thereby enhancing decision-making processes in clinical settings and accelerating discoveries in genomics. With its focus on improving cancer diagnosis and treatment, Genomenon aims to support better patient outcomes through its innovative software solutions.

EverWash

Series B in 2022
EverWash Car Club is a technology-driven company specializing in the car wash industry through its mobile-powered Membership Sales and Subscription Management Platform. The company operates a cloud-based subscription management platform that automates the entire process of membership sales, marketing, and management. This includes customer enrollment, billing, and revenue recognition. By providing a user-friendly mobile application, EverWash allows customers to easily find, purchase, and manage their monthly car wash memberships securely from their smartphones. This innovative approach helps car wash operators achieve significant revenue growth while enhancing customer retention and operational efficiency.

Eyrus

Series A in 2022
Eyrus is a workforce visibility platform specifically designed for the construction industry. It automates the collection of workforce data, enabling project teams to enhance attendance, timekeeping, safety, and security in real time. By implementing Eyrus during workforce registration, companies can capture essential information related to OSHA, health and safety, and equipment training through a user-friendly worker profile. Utilizing IoT technology and mobile devices, Eyrus tracks workforce interactions across job sites, providing features such as access control, real-time evacuation alerts, and compliance reporting metrics. This cloud-based platform allows for the generation of actionable insights and analytics, helping clients manage resources efficiently, ensure project safety, and improve delivery timelines. The data collected also assists in schedule forecasting and understanding potential delays, thereby enhancing overall decision-making and project planning.

Koneksa

Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

Ankyra

Series B in 2021
Ankyra is a biotech company focused on developing anchored immunotherapy to enhance cancer treatment. The company's innovative approach addresses the challenges associated with traditional cytokine therapeutics, which often face limitations due to widespread immune activation and toxicity when administered systemically. Ankyra utilizes its Anchored Immunotherapy Platform to create ANK-101, a stable complex that combines a modified IL-12 cytokine with an FDA-approved adjuvant, aluminum hydroxide, which helps to retain the cytokine's potent activity at the tumor site. This localized delivery results in targeted inflammation that activates an anti-tumor immune response while minimizing adverse effects. Ankyra aims to optimize the efficacy and safety of its therapies, ultimately improving treatment outcomes for cancer patients.

Aware

Series C in 2021
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Lessonbee

Seed Round in 2021
Lessonbee Inc. is an educational technology company that specializes in providing an online learning platform and digital curriculum focused on health and wellness for students in grades K-12. Founded in 2017 and based in Mount Vernon, New York, Lessonbee offers a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform enables teachers to access up-to-date, culturally responsive, and medically accurate health education content, track student assignments, and foster student engagement through regular reflection. Additionally, Lessonbee incorporates its proprietary HealthIQ analytics to evaluate student health goals and school climate, recommending personalized content from its extensive library of self-paced classes and video-based lessons aligned with state and national health education standards. By promoting collaboration among educators, parents, and healthcare providers, Lessonbee aims to enhance student well-being and health literacy.

RepairSmith

Series B in 2021
RepairSmith is a company that offers convenient car repair and maintenance services. Car owners can choose to have their repairs done at their own driveway or drop off their vehicle at the company's shop. They provide upfront pricing, online booking, after-hours support, and a full warranty for their services. RepairSmith's mechanics are equipped with company vehicles and professional tools, and are trained to prioritize customer satisfaction.

Allyx Therapeutics

Venture Round in 2021
Allyx Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2018 and based in Durham, Connecticut. The company specializes in developing disease-modifying treatments for Alzheimer's Disease, with a focus on reversing neurodegeneration. Its lead product is an orally bioavailable small molecule that functions as a silent allosteric modulator of mGluR5. This innovative approach aims to provide clinicians with a therapeutic option capable of preserving cognition in patients while addressing the underlying disease mechanisms.

Thentia Cloud

Series B in 2021
Thentia Cloud is a leading company that specializes in providing regulatory, compliance, and governance database services. The company leverages proprietary technology to assist regulatory bodies in efficiently meeting their obligations. Thentia serves a diverse range of clients across Canada and the United States, offering cutting-edge software solutions and industry-leading expertise in regulatory standards. Their product suite includes a secure, user-friendly platform for regulators and a cloud-based compliance solution designed for private businesses, boards of directors, committees, executive teams, and stakeholders. This enables both public and private entities to maintain high standards of regulatory excellence in a timely and professional manner.

Aware

Series B in 2020
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Koneksa

Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

Maven Clinic

Series C in 2020
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

IsoPlexis

Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

IsoPlexis

Series C in 2019
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

Keen Decision Systems

Series A in 2019
Keen Decision Systems, LLC is a software developer based in Durham, North Carolina, specializing in marketing measurement and optimization platforms. Founded in 2010, the company provides a software-as-a-service solution that empowers marketers to make informed, data-driven decisions. Its technology offers real-time insights into the financial contributions of various marketing channels, enabling users to optimize their investments while maximizing profitability and revenue. The platform assists marketers in determining the most effective timing for expenditures, adapting strategies to market changes, and planning future actions.

Maven Clinic

Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

RiskSense

Series B in 2018
RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risk effectively. The RiskSense Platform provides vulnerability prioritization and management, utilizing risk-based scoring and analytics to identify critical security weaknesses. It features services such as vulnerability assessments and attack surface validation, which help organizations discover misconfigurations and vulnerabilities, as well as assess potential infiltration paths used by cyber adversaries. By continuously correlating customer infrastructure with extensive vulnerability data and threat intelligence, RiskSense delivers actionable insights that prioritize remediation efforts and enhance overall security posture. Founded in 2006 and headquartered in Sunnyvale, California, with additional offices in Albuquerque, New Mexico, and India, RiskSense was previously known as CAaNES, LLC before rebranding in May 2015.

Vergent Bioscience

Series A in 2018
Vergent Bioscience, Inc. is a company focused on improving cancer surgery outcomes through the development of molecularly-targeted imaging probes. Founded in 2013 and based in Minneapolis, Minnesota, Vergent manufactures a tumor-targeted fluorescent probe, known as VGT-309, which binds to enzymes overexpressed in various cancerous tissues. Upon injection prior to surgery, this probe activates a bright fluorescing dye that illuminates cancerous cells, allowing surgeons to differentiate between malignant and normal tissue with enhanced clarity. By providing a clear visual guide during surgical procedures, Vergent's technology aims to facilitate the complete removal of tumors and reduce the likelihood of residual cancer, thereby addressing a critical need in the surgical oncology field. The company's innovative approach is applicable to multiple cancer types, including lung, breast, ovarian, colorectal, and brain cancers, and is designed to support advanced visualization in various surgical techniques, including open, laparoscopic, and robotic surgeries.

ReNetX Bio

Series A in 2018
ReNetX Bio, Inc. is a biotechnology company focused on developing and marketing therapeutics aimed at treating injuries and damage to the central nervous system (CNS). The company provides Nogo Trap, a decoy receptor that binds growth inhibitors to facilitate natural nerve fiber growth, promoting axonal regeneration, sprouting, and synaptic plasticity. ReNetX Bio's therapeutic offerings address conditions such as spinal cord injury, stroke, and glaucoma. The company, originally founded as Axerion Therapeutics in 2009, rebranded to ReNetX Bio in July 2017 and is headquartered in New Haven, Connecticut. Its innovative approach includes the development of small molecule oral compounds designed to block harmful protein interactions in the brain, thereby supporting recovery in patients with various CNS disorders.

Home Captain

Series A in 2018
Home Captain Inc. is a technology-driven real estate company based in New York, founded in 2013. It offers a comprehensive platform that connects home buyers and sellers with local real estate agents, enhancing the overall customer experience in the property market. The company provides a suite of services, including a web and mobile MLS-integrated home search app, AI-powered chat support, and concierge services to assist clients throughout the buying and selling process. Additionally, Home Captain features agent screening and management tools, as well as a patent-pending technology for matching clients with suitable agents. The platform also offers specialized services for veterans, providing competitive interest rate quotes and tailored guidance to help them navigate the complexities of homeownership. By integrating these tools and services, Home Captain aims to streamline real estate transactions and support mortgage lenders in maintaining customer relationships.

180 Health Partners

Series B in 2018
180 Health Partners, Inc. is a healthcare organization focused on addressing substance use and behavioral health challenges, particularly in pregnant women. Founded in 2016 and based in Franklin, Tennessee, the company offers comprehensive services aimed at supporting expecting mothers struggling with addiction. Through its signature programs, The 180 Way and StrongWell, 180 Health Partners combines personalized interdisciplinary treatment with a relationship-based support ecosystem to facilitate recovery and ensure the delivery of healthy babies. The organization emphasizes multi-modal care coordination, connecting mothers with healthcare providers through various communication channels, including phone, video, text, and email. By enabling access to medical care in home or preferred locations, the company aims to improve health outcomes while also addressing the financial aspects of care.

IsoPlexis

Series B in 2017
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

Maven Clinic

Series A in 2017
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

SimpleReach

Series B in 2017
SimpleReach, Inc. is a New York-based company that offers a platform for tracking social engagement on published content, providing insights and metrics related to social behavior. Founded in 2010, SimpleReach consolidates content data from various channels to present a comprehensive view of content performance. The platform delivers actionable insights that assist clients in enhancing the return on their content investments, utilizing advanced machine learning and artificial intelligence methods. SimpleReach enables marketers to refine their future campaigns and allows publishers to create dashboards for monitoring and improving their programs. The company's services are relied upon by notable brands such as Intel, Chase, and Home Depot, who use the platform to better understand the impact of their content on business outcomes. SimpleReach was previously known as SimplePR Inc. and currently operates as a subsidiary of Nativo, Inc.

Doctor.com

Series A in 2017
Doctor.com is a healthcare marketing automation platform designed specifically for healthcare organizations to improve the digital patient experience. The company provides a range of services, including reputation management, patient acquisition, and online scheduling, all aimed at enhancing the visibility and credibility of healthcare providers. Its proprietary network connects to numerous consumer health and local business sites, allowing clients to reach over 100 million patients each month. By integrating data management and patient communication tools, Doctor.com helps healthcare organizations build trust with patients and streamline their operations, positioning itself as a leader in the healthcare SaaS sector. As one of the fastest-growing companies in this niche, it is supported by a skilled team and notable investors.

Prevalent

Series B in 2016
Prevalent, Inc. specializes in third-party risk management software and services designed to help organizations mitigate security and compliance risks associated with vendors and suppliers throughout the third-party lifecycle. Founded in 2004 and headquartered in Phoenix, Arizona, Prevalent offers a range of solutions, including Vendor Risk Manager, which assesses vendor risk based on their significance to the organization, and Vendor Threat Monitor, which tracks various risk areas such as data and operational risks. The company also provides a Policy Portal for governance management and a Legal Vendor Network aimed at law firms for monitoring third-party security risks. Prevalent's offerings include compliance services tailored to meet global regulatory requirements, as well as professional services like vulnerability assessments and incident management. Additionally, the firm operates networks specific to sectors like healthcare, ensuring robust security and privacy measures are in place. With offices in multiple locations, including the U.S. and the U.K., Prevalent operates as a subsidiary of iMedX, Inc.

Oncoceutics

Series A in 2015
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania. Founded in 2009, the company focuses on targeting potent tumor suppressor pathways in human cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist that has demonstrated significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 selectively engages apoptotic response mechanisms within tumors, allowing for a cytotoxic effect while sparing normal cells, which contributes to its favorable safety profile. The company is currently evaluating ONC201 in multiple clinical trials at leading cancer centers globally, reflecting its potential for safe and meaningful therapeutic benefits for cancer patients. Oncoceutics' strategic alliances with institutions such as the National Institutes of Health and Calvert Research, LLC, further support its mission to advance innovative cancer treatments.

Ziften

Series C in 2015
Ziften is a privately funded endpoint security company located in Austin, Texas, specializing in cloud-delivered solutions for endpoint protection. The organization offers a platform that simplifies the management of endpoint security across various devices, including laptops, desktops, servers, and cloud environments. Ziften's services include advanced protection against cyber threats, endpoint detection and response, and security posture analysis. By enabling businesses to monitor and control applications and processes in both physical and virtual Windows desktop environments, Ziften helps organizations safeguard their documents and critical data from potential cyber attacks.

Activate Healthcare

Venture Round in 2015
Activate Healthcare, LLC is a provider of proactive primary care services, primarily focused on serving employees of medium-sized enterprises. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company offers a range of healthcare services, including treatment for minor illnesses, chronic condition management, and preventive care such as wellness exams and screenings. Activate Healthcare also emphasizes patient engagement by utilizing predictive modeling tools to identify high-risk individuals, enabling medical staff to actively support these patients in managing their health risks. The company serves various sectors, including government organizations, schools, and manufacturing and transportation industries, aiming to empower patients to take charge of their health. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.

OpenSlate

Series A in 2015
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content, established in 2012 by CEO Mike Henry and headquartered in New York, NY. The company specializes in measuring brand suitability for advertisers, offering targeted solutions that enhance the alignment of advertising with appropriate content. Unlike traditional methods that focus on post-exposure monitoring, OpenSlate employs predictive data science and proprietary analytics to generate actionable insights at a large scale. This technology supports the needs of major digital video platforms, particularly YouTube, while also being applicable across various video content on the web. OpenSlate's platform is utilized by major advertising holding companies and prominent brands, positioning the company as a critical player in the digital advertising landscape.

Oncoceutics

Venture Round in 2014
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania. Founded in 2009, the company focuses on targeting potent tumor suppressor pathways in human cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist that has demonstrated significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 selectively engages apoptotic response mechanisms within tumors, allowing for a cytotoxic effect while sparing normal cells, which contributes to its favorable safety profile. The company is currently evaluating ONC201 in multiple clinical trials at leading cancer centers globally, reflecting its potential for safe and meaningful therapeutic benefits for cancer patients. Oncoceutics' strategic alliances with institutions such as the National Institutes of Health and Calvert Research, LLC, further support its mission to advance innovative cancer treatments.

Activate Healthcare

Private Equity Round in 2014
Activate Healthcare, LLC is a provider of proactive primary care services, primarily focused on serving employees of medium-sized enterprises. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company offers a range of healthcare services, including treatment for minor illnesses, chronic condition management, and preventive care such as wellness exams and screenings. Activate Healthcare also emphasizes patient engagement by utilizing predictive modeling tools to identify high-risk individuals, enabling medical staff to actively support these patients in managing their health risks. The company serves various sectors, including government organizations, schools, and manufacturing and transportation industries, aiming to empower patients to take charge of their health. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.

IsoPlexis

Series A in 2014
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

HμREL

Series A in 2013
HμREL® Corporation is an early-stage bioanalytic tools company with operations based in Kenilworth and New Brunswick, New Jersey, USA. Robert Freedman serves as Chief Executive Officer. Martin Yarmush is the Company’s Chief Scientific Adviser.

WhipTail

Series C in 2012
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.

OpenSlate

Series A in 2012
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content, established in 2012 by CEO Mike Henry and headquartered in New York, NY. The company specializes in measuring brand suitability for advertisers, offering targeted solutions that enhance the alignment of advertising with appropriate content. Unlike traditional methods that focus on post-exposure monitoring, OpenSlate employs predictive data science and proprietary analytics to generate actionable insights at a large scale. This technology supports the needs of major digital video platforms, particularly YouTube, while also being applicable across various video content on the web. OpenSlate's platform is utilized by major advertising holding companies and prominent brands, positioning the company as a critical player in the digital advertising landscape.

WhipTail

Series B in 2012
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.

WhipTail

Series A in 2011
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.

NXTM

Private Equity Round in 2011
Led by a former senior MTV executive, NXTM powers the digital presence for superstars Taylor Swift, Justin Timberlake, and Lenny Kravitz. Via its platform WHOOZNXT, NXTM equips emerging artists with these same tools and top-tier exposure opportunities. With major media partnerships in television, radio, live venues, digital platforms, and more - WHOOZNXT is the only platform that rewards the online activity of artists with real-world exposure.

Coolerado

Series B in 2010
Coolerado Corporation is a manufacturer of air conditioning systems based in Denver, Colorado, founded in 2004. The company specializes in designing, manufacturing, and marketing super-energy-efficient air conditioning systems for light commercial and residential use. Utilizing proprietary and patented technology, Coolerado's products include heat and mass exchangers, compact and modular air conditioners, and energy recovery ventilators. These systems are employed across various sectors, including data centers, schools, healthcare, food and beverage, and military applications. Coolerado aims to reduce energy consumption, improve indoor air quality, and reduce carbon emissions, serving a global customer base through a network of dealers. As of June 2015, Coolerado operates as a subsidiary of Seeley International Pty Ltd.

Perquest

Series B in 2007
Perquest is a company that specializes in redefining workforce solutions through innovative technology and dedicated service. It focuses on delivering high-quality payroll services and an integrated suite of human resources applications tailored for mid-size companies. By incorporating advanced customer relationship management technology, Perquest ensures transparency and responsiveness, allowing clients to communicate easily through a secure Client Portal. The company's philosophy centers around simplicity, aiming to make its solutions user-friendly for employees, customers, and partners alike. Perquest's commitment to reliability and service excellence positions it as a valuable partner for smaller employers seeking efficient and effective workforce management solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.